![]() ![]() The latest release of information from the E3N, published in the Journal of the American Heart Association, examined the risk of stroke among women using oral (pill) estrogen, transdermal estrogen (patch or gel), different kinds of progestins, and progesterone. The Women’s Health Initiative study found that users of the hormone replacement drug PremPro had a 41% higher risk of stroke, so it’s important to distinguish between the risk factors of the synthetic hormones in PremPro and the risk factors for bioidentical hormones. Stroke is the third leading cause of death among women in the U.S., and although more men than women have strokes, more women die from them. ![]() The E3N study is following nearly 100,000 menopausal women over time. The most common kind of hormone replacement therapy used by French women is a combination of estradiol patch or gel, and oral progesterone-both bioidentical hormones. The large, ongoing French E3N study is providing valuable safety data for users of bioidentical hormones, most recently on estrogen, progesterone and the risk of stroke. Valuable New Research on Bioidentical Hormones and Stroke ![]()
0 Comments
Leave a Reply. |